Eculizumab in paroxysmal nocturnal hemoglobinuria

被引：0

作者：

Socie, Gerard ^{[1
]}

Varoqueaux, Nathalie ^{[2
]}

de Latour, Regis Peffault ^{[1
]}

机构：

[1] Hop St Louis, INSERM, AP HP, Serv Hematol Greffe,U728, F-75010 Paris, France

[2] Alexion Pharma France, Direct Affaires Med, F-75008 Paris, France

来源：

M S-MEDECINE SCIENCES | 2009年 / 25卷 / 12期

关键词：

COMPLEMENT INHIBITOR ECULIZUMAB; PIG-A GENE; MICROPARTICLES; HEMOLYSIS; DISEASE;

D O I：

10.1051/medsci/200925121126

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Eculizumab in paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal hemoglobinuria is a rare acquired clonal of the hematopoietic stem cell due to acquired mutation of the PIG-A gene. This results in the lack of two GPI-anchored membrane proteins involved in the inhibition of complement attack, thus explaining red cells hemolysis. The development of an anti-C5 monoclonal antibody (eculizumab) had profoundly modified the treatment of the the hemolytic form of the disease.

引用

页码：1126 / 1129

页数：4

共 50 条

[31] Efficacy and Safety of Eculizumab in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria
Reiss, Ulrike M.
Schwartz, Jeffrey
Sakamoto, Kathleen M.
Puthenveetil, Geetha
Ogawa, Masayo
Bedrosian, Camille L.
Ware, Russell E.
PEDIATRIC BLOOD & CANCER, 2014, 61 (09) : 1544 - 1550
[32] Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab
Danilov, Alexey V.
Brodsky, Robert A.
Craigo, Sabrina
Smith, Hedy
Miller, Kenneth B.
LEUKEMIA RESEARCH, 2010, 34 (05) : 566 - 571
[33] EXTRAVASCULAR HEMOLYSIS DURING TREATMENT WITH ECULIZUMAB FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Graciaa, Sara
Chonat, Satheesh
PEDIATRIC BLOOD & CANCER, 2019, 66
[34] Efficacy and Safety of Eculizumab in Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria
Reiss, Ulrike M.
Schwartz, Jeffrey
Sakamoto, Kathleen M.
Puthenveetil, Geetha
Ogawa, Masayo
Ware, Russell E.
BLOOD, 2011, 118 (21) : 477 - 478
[35] Eculizumab Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). the Argentinian Experience
Brodsky, Andres L.
Touliet, Valeria Soledad
Rocaspana, Adriana
Aldunate, Ximena
Alzueta, Abel Esteban
Barraza, Teresa
Beguelin, Raul
Carnpregher, Gabriel
Beatriz Colin, Laura
Dinardo, Pablo
Gotta, Daniel
Oliveira, Natalia
Parodi, Claudia
Perinotto, Gabriela
Ramirez, Mario
Rigada, Guillermina
Ronzzetti, Rosanna
Esther, Rosenfeld
Blanca, Rossi
Stivel, Miriam
Zirone, Sandra
BLOOD, 2015, 126 (23)
[36] Antiphospholipid antibodies in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
Helley, D.
Darnige, L.
de Latour, R. P.
Zemori, L.
Socie, G.
Fischer, A-M
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 624 - 624
[37] Ham Test For Therapeutic Monitoring Of Eculizumab In Paroxysmal Nocturnal Hemoglobinuria
Arcavi, Miriam
Ceballo, Fernanda
Brodsky, Andres L.
Halperin, Nora Silvia
Cantenys, Norma
Colin, Laura Beatriz
Malusardi, Cecilia
Lazarowski, Alberto
BLOOD, 2013, 122 (21)
[38] Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria
Seregina, E. A.
Tsvetaeva, N. V.
Nikulina, O. F.
Zapariy, A. P.
Erasov, A. V.
Gribkova, I. V.
Orel, E. B.
Ataullakhanov, F. I.
Balandina, A. N.
BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (02) : 144 - 150
[39] Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond
Risitano, A. M.
Scalia, G.
Marando, L.
Ranaldi, D.
Ricci, P.
Selleri, C.
Rodeghiero, F.
Zanella, A.
Iori, A. P.
Luzzafto, L.
Del Vecchio, L.
Rotoli, B.
CYTOMETRY PART A, 2008, 73A (01) : 53 - 54
[40] Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond
Risitano, A. M.
Hill, A.
Ricci, F.
Selleri, C.
Marando, L.
Gianfaldoni, G.
Marinelli, F.
Milano, F.
Amendola, A.
Boschetti, C.
Di Bona, E.
Barbano, E.
D'Amico, P.
Rodeghierc, F.
Zanella, A.
Iori, A. P.
Notaro, R.
Rother, R. P.
Kroon, H. A.
Hillmen, P.
Luzzatto, L.
Rotoli, B.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 89 - 90

← 1 2 3 4 5 →